Multiple cellular and metabolic pathways

The term Multiple cellular and metabolic pathways does not refer to a single molecular target, such as a specific protein or receptor, but rather describes a broad set of biological processes influenced by certain pharmacological agents. This classification is typically used for drugs that exhibit pleiotropy, where the therapeutic effect is the result of interacting with various enzymes, signaling molecules, and metabolic intermediates rather than a solitary lock-and-key mechanism (Rena et al., 2017). For instance, compounds like metformin or various polyphenols are often described in this manner because they modulate energy sensors like AMPK, mitochondrial function, and inflammatory pathways concurrently (Pollak, 2012). Because it encompasses a broad spectrum of physiological functions, it does not represent a specific protein, gene, or receptor that can be isolated for traditional structure-based drug design. In a drug discovery context, this term serves as a placeholder for complex, multi-faceted mechanisms of action that are not yet fully resolved into individual target components. Consequently, it is considered an incorrect or non-specific target designation for structured bioinformatics databases.

Other names

Pleiotropic pathwaysMulti-target mechanismsSystemic metabolic networks

Simultaneous modulation of diverse biochemical cascades and enzymatic activities across different cellular compartments.